Regentis Biomaterials RGNT
NYSE RGNT
$1.50 +0.03 (+2.40%)
As of: Oct 21, 2026 · 12:57 PM EDT

Regentis Biomaterials (RGNT) Accounts Payables (2024 - 2026)

Updated

Regentis Biomaterials (RGNT) reported Accounts Payables of $195,000 for Q2 2026.

Analysis

Regentis Biomaterials (RGNT) Accounts Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Regentis Biomaterials posted Accounts Payables of $266,000, up 5.6% from FY2024.

  • By year, Accounts Payables came in at $252,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Thermo Fisher Scientific 258.23 Bn 237.26 Bn 4.88 Bn 3.27 Bn
2 Abbott Laboratories 171.33 Bn 141.76 Bn 7.27 Bn 4.79 Bn
3 Danaher 162.29 Bn 146.09 Bn 3.61 Bn 1.82 Bn
4 Intuitive Surgical 151.16 Bn 130.58 Bn 1.96 Bn 277.20 Mn
5 Medtronic 119.57 Bn 84.82 Bn 6.34 Bn 2.70 Bn
6 Stryker 113.73 Bn 99.85 Bn 4.50 Bn 1.66 Bn
7 Boston Scientific 65.12 Bn 59.89 Bn 3.85 Bn 1.23 Bn
8 Becton Dickinson 53.54 Bn 50.69 Bn 2.32 Bn 6.11 Bn
9 Edwards Lifesciences 50.79 Bn 34.79 Bn 1.35 Bn 210.50 Mn
10 Regentis Biomaterials 852,949.72 852,949.72 - 195,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 195,000.00
Dec 31, 2025 266,000.00
Dec 31, 2024 252,000.00
API Access

Regentis Biomaterials Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=RGNT&period=max&api_key=YOUR_API_KEY